The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000773336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
12/06/2026
Date registered
Help: Date registered
29/06/2026
Date last updated
Help: Date last updated
1/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
29/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Brain blood flow monitoring during personalised external aortic root support (PEARS) surgery and postoperative outcomes
Scientific title
Intraoperative cerebral autoregulation monitoring using wavelet semblance analysis in patients undergoing Personalised External Aortic Root Support surgery
Additional trial identifiers [1] 317564 0
Nil known
Universal Trial Number (UTN)
Trial acronym
WAVELET-II
Related trial records

Health condition
Health condition(s) studied:
Aortic root aneurysm 342314 0
Condition category
Condition code
Cardiovascular 338439 338439 0 0
Other cardiovascular diseases
Anaesthesiology 338440 338440 0 0
Anaesthetics

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of the intervention or exposure
Participants undergoing elective Personalised External Aortic Root Support (PEARS) surgery will provide written informed consent for prospective observational collection of perioperative physiological data, clinical outcome data, blood samples, and follow-up assessments. The study will not alter routine clinical management and all participants will receive standard perioperative care.

Participants will undergo brief preoperative cognitive screening using the Telephone Interview for Cognitive Status (TICS), which takes approximately 5–10 minutes. During surgery, routine invasive arterial blood pressure monitoring, regional cerebral oxygen saturation (rSO2) using near-infrared spectroscopy (NIRS), processed electroencephalography using BIS, and routine physiological monitoring data will be recorded. Additional non-invasive research monitoring will include broadband NIRS to assess cytochrome c oxidase (oxCCO), and transcranial Doppler monitoring of cerebral blood flow velocity where feasible. These data will be analysed offline using wavelet semblance analysis to determine the lower limit of cerebral autoregulation (LLA) and quantify the duration and magnitude of mean arterial pressure below the LLA.

Blood samples for study biomarkers will be collected at baseline, 24 hours, and 48 hours postoperatively, timed where possible to coincide with routine blood draws or obtained from clinically indicated vascular access. Delirium screening will be performed twice daily from postoperative day 0 to day 3 using CAM-ICU for intubated patients or UB-CAM for extubated patients. Participants may also choose to participate in an optional postoperative brain MRI sub-study, performed prior to discharge on postoperative day 5 ±2, subject to clinical stability and MRI safety requirements.

Participants will be observed from enrolment before surgery until completion of postoperative follow-up, including in-hospital outcome assessment and day-30 postoperative cognitive assessment.
Intervention code [1] 334353 0
Diagnosis / Prognosis
Description of the comparator or control
No control group. This is a prospective observational study in which all participants undergo elective Personalised External Aortic Root Support (PEARS) surgery with physiological monitoring and postoperative outcome assessment.
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345739 0
Percentage of participants in whom the lower limit of cerebral autoregulation can be determined
Timepoint [1] 345739 0
Intraoperative assessment (primary timepoint)
Secondary outcome [1] 463098 0
Postoperative delirium
Timepoint [1] 463098 0
Twice daily from postoperative day 0 to postoperative day 3
Secondary outcome [2] 463099 0
Acute kidney injury
Timepoint [2] 463099 0
Baseline, 0-2 hours, 24 hours and 48 hours after surgery
Secondary outcome [3] 463100 0
Cerebral mitochondrial metabolism
Timepoint [3] 463100 0
During surgery
Secondary outcome [4] 463101 0
Dynamic cerebral autoregulation
Timepoint [4] 463101 0
During surgery
Secondary outcome [5] 463102 0
Perioperative glial fibrillary acidic protein (GFAP) concentration
Timepoint [5] 463102 0
Baseline, 24 hours postoperatively, and 48 hours postoperatively.
Secondary outcome [6] 463440 0
Perioperative S100B concentration
Timepoint [6] 463440 0
Baseline, 24 hours postoperatively, and 48 hours postoperatively.
Secondary outcome [7] 463443 0
Perioperative neurofilament light chain (NfL) concentration
Timepoint [7] 463443 0
Baseline, 24 hours postoperatively, and 48 hours postoperatively.
Secondary outcome [8] 463445 0
Perioperative neuron-specific enolase (NSE) concentration
Timepoint [8] 463445 0
Baseline, 24 hours postoperatively, and 48 hours postoperatively.
Secondary outcome [9] 463447 0
New diffusion-weighted imaging (DWI)-defined cerebral ischaemic lesions
Timepoint [9] 463447 0
Postoperative day 5 (±2 days), prior to hospital discharge, subject to clinical stability and MRI eligibility

Eligibility
Key inclusion criteria
Adults aged 18 years or older undergoing elective Personalised External Aortic Root Support (PEARS) surgery at The Prince Charles Hospital who are able and willing to provide informed consent and undergo general anaesthesia.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Inability or unwillingness to provide informed consent; age under 18 years; not undergoing elective Personalised External Aortic Root Support (PEARS) surgery; contraindication to near-infrared spectroscopy monitoring (including dermatitis or allergy to adhesive dressings). Participants in the optional MRI sub-study will be excluded if they have contraindications to MRI.

Study design
Purpose
Natural history
Duration
Longitudinal
Selection
Defined population
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 322122 0
Charities/Societies/Foundations
Name [1] 322122 0
The Common Good
Country [1] 322122 0
Australia
Funding source category [2] 322123 0
Charities/Societies/Foundations
Name [2] 322123 0
Australian Society of Anaesthetists
Country [2] 322123 0
Australia
Funding source category [3] 322124 0
University
Name [3] 322124 0
The University of Queensland
Country [3] 322124 0
Australia
Primary sponsor type
University
Name
The University of Queensland
Address
Country
Australia
Secondary sponsor category [1] 325014 0
Hospital
Name [1] 325014 0
The Prince Charles Hospital, Metro North, Queensland
Address [1] 325014 0
Country [1] 325014 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320651 0
Metro North Health Human Research Ethics Committee
Ethics committee address [1] 320651 0
Ethics committee country [1] 320651 0
Australia
Date submitted for ethics approval [1] 320651 0
01/09/2025
Approval date [1] 320651 0
03/11/2025
Ethics approval number [1] 320651 0
HREC/2025/MNH/122439

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151174 0
Dr Matthew Bright
Address 151174 0
The Prince Charles Hospital, 627 Rode Road, Chermside, Queensland 4032
Country 151174 0
Australia
Phone 151174 0
+61400202446
Fax 151174 0
Email 151174 0
Contact person for public queries
Name 151175 0
Matthew Bright
Address 151175 0
The Prince Charles Hospital, 627 Rode Road, Chermside, Queensland 4032
Country 151175 0
Australia
Phone 151175 0
+61073139 4000
Fax 151175 0
Email 151175 0
Contact person for scientific queries
Name 151176 0
Matthew Bright
Address 151176 0
The Prince Charles Hospital, 627 Rode Road, Chermside, Queensland 4032
Country 151176 0
Australia
Phone 151176 0
+610731394000
Fax 151176 0
Email 151176 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.